Vivet Therapeutics
Paris, FR · Founded 2016 · 17 employees on LinkedIn · 8 known investors
Vivet Therapeutics is a clinical-stage biotechnology company developing recombinant adeno-associated virus (rAAV) gene therapies for rare, inherited metabolic diseases, including Wilson's Disease and cerebrotendinous xanthomatosis. Its pipeline is built on technologies licensed from FIMA at the University of Navarra in Spain.
Investors · 8
HealthCap✓ verifiedStockholm
Kurma Partners✓ verifiedParis · $162K – $10.8M
Novartis Venture Fund✓ verifiedBasel · $5M – $25M
Roche Venture Fund✓ verifiedBasel · $648K – $3.2M
Ysios Capital✓ verifiedBarcelona · $5.4M – $21.6M
Columbus Venture Partners✓ verifiedValenciavia Jose Mesa · inferred
Eurazeo✓ verifiedParis
Pfizer Venture Investments$5M – $20M
Competitors · 7
by search overlap
Clementia13 shared keywordsIpsen is a biopharmaceutical group that publishes financial, legal, and non-financial reporting for shareholders, investors, and the public through documents such as its Universal Registration Document. The page is the investor reports and accounts section of the company's corporate site.
Gatsby11 shared keywordsGatsby is an event management platform that sends invitations from partners' actual email accounts and provides customizable registration pages with guest profiles and adaptive forms.
Jefferies11 shared keywordsJefferies is a financial services firm offering investment banking, wealth management, and related capital markets services. The captured page is a multilingual fraud-alert notice warning that impersonators are misusing the Jefferies name to solicit fake investments and jobs.
IO Biotech10 shared keywordsIOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.
Kodiak Sciences10 shared keywordsKodiak Sciences develops biopharmaceutical therapies for chronic ophthalmic diseases, with a focus on patient outcomes and stakeholder impact in the healthcare system.
PrecisionLife10 shared keywordsPrecisionLife uses advanced AI and analytics to identify the biological mechanisms underlying complex chronic diseases, enabling earlier diagnosis and more personalized treatment selection. The company develops diagnostic tests, clinical tools, and insights for pharmaceutical and healthcare partners to improve disease understanding and patient outcomes across multiple therapeutic areas.
Medscape10 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Companies competing with Vivet Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Vivet Therapeutics do?
- Vivet Therapeutics is a clinical-stage biotechnology company developing recombinant adeno-associated virus (rAAV) gene therapies for rare, inherited metabolic diseases, including Wilson's Disease and cerebrotendinous xanthomatosis. Its pipeline is built on technologies licensed from FIMA at the University of Navarra in Spain.
- Who are Vivet Therapeutics's investors?
- Vivet Therapeutics's investors include HealthCap, Kurma Partners, Novartis Venture Fund, Roche Venture Fund, Ysios Capital, Columbus Venture Partners, Eurazeo, Pfizer Venture Investments.
- Where is Vivet Therapeutics headquartered?
- Vivet Therapeutics is headquartered in Paris, FR.